{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:32:17Z","timestamp":1785843137215,"version":"3.56.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T00:00:00Z","timestamp":1576195200000},"content-version":"vor","delay-in-days":652,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100008762","name":"Genome Canada","doi-asserted-by":"publisher","award":["4108"],"award-info":[{"award-number":["4108"]}],"id":[{"id":"10.13039\/100008762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000233","name":"Genome British Columbia","doi-asserted-by":"publisher","award":["141LYM"],"award-info":[{"award-number":["141LYM"]}],"id":[{"id":"10.13039\/501100000233","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["148393"],"award-info":[{"award-number":["148393"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004376","name":"Terry Fox Research Institute","doi-asserted-by":"publisher","award":["1061"],"award-info":[{"award-number":["1061"]}],"id":[{"id":"10.13039\/501100004376","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","journals.elsevierhealth.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Molecular Diagnostics"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.jmoldx.2017.11.010","type":"journal-article","created":{"date-parts":[[2018,2,8]],"date-time":"2018-02-08T04:08:10Z","timestamp":1518062890000},"page":"203-214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"title":["Assessment of Capture and Amplicon-Based Approaches for the Development of a Targeted Next-Generation Sequencing Pipeline to Personalize Lymphoma Management"],"prefix":"10.1016","volume":"20","author":[{"given":"Stacy S.","family":"Hung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Meissner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Chavez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Ben-Neriah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Ennishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin R.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hennady P.","family":"Shulha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fong Chun","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merrill","family":"Boyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Kridel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randy D.","family":"Gascoyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Mungall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco A.","family":"Marra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph M.","family":"Connors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Steidl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmoldx.2017.11.010_bib1","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib2","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1158\/1541-7786.MCR-10-0264","article-title":"Personalized medicine: marking a new epoch in cancer patient management","volume":"8","author":"Diamandis","year":"2010","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib3","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jmoldx.2012.04.006","article-title":"Opportunities and challenges associated with clinical diagnostic genome sequencing: a report of the Association for Molecular Pathology","volume":"14","author":"Schrijver","year":"2012","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib4","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S1470-2045(15)00169-2","article-title":"Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry","volume":"16","author":"Pastore","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib5","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/nm.3884","article-title":"Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma","volume":"21","author":"Wilson","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib6","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1182\/blood-2015-07-659144","article-title":"Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia","volume":"127","author":"Nadeu","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib7","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nrg3445","article-title":"Cancer genome-sequencing study design","volume":"14","author":"Mwenifumbo","year":"2013","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib8","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1158\/1078-0432.CCR-16-0232","article-title":"Precision medicine for diffuse large B-cell lymphoma","volume":"22","author":"Lim","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nmeth.1419","article-title":"Target-enrichment strategies for next-generation sequencing","volume":"7","author":"Mamanova","year":"2010","journal-title":"Nat Methods"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib10","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1515\/hsz-2013-0199","article-title":"Enrichment of target sequences for next-generation sequencing applications in research and diagnostics","volume":"395","author":"Altmuller","year":"2014","journal-title":"Biol Chem"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib11","doi-asserted-by":"crossref","first-page":"19096","DOI":"10.1073\/pnas.0910672106","article-title":"Genetic diagnosis by whole exome capture and massively parallel DNA sequencing","volume":"106","author":"Choi","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib12","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/humu.22825","article-title":"Evaluation of hybridization capture versus amplicon-based methods for whole-exome sequencing","volume":"36","author":"Samorodnitsky","year":"2015","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib13","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/gim.2015.121","article-title":"Capture-based high-coverage NGS: a powerful tool to uncover a wide spectrum of mutation types","volume":"18","author":"Wang","year":"2016","journal-title":"Genet Med"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib14","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.1038\/srep03494","article-title":"Targeted-capture massively-parallel sequencing enables robust detection of clinically informative mutations from formalin-fixed tumours","volume":"3","author":"Wong","year":"2013","journal-title":"Sci Rep"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib15","unstructured":"Li H: Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. arXiv.org 2013, 1303.3997:1\u20133"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib16","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1101\/gr.129684.111","article-title":"VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing","volume":"22","author":"Koboldt","year":"2012","journal-title":"Genome Res"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib17","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1093\/bioinformatics\/bts271","article-title":"Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs","volume":"28","author":"Saunders","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib18","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nbt.1754","article-title":"Integrative genomics viewer","volume":"29","author":"Robinson","year":"2011","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib19","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1093\/bioinformatics\/btt305","article-title":"Mutascope: sensitive detection of somatic mutations from deep amplicon sequencing","volume":"29","author":"Yost","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib20","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1093\/nar\/gks596","article-title":"Primer3\u2013new capabilities and interfaces","volume":"40","author":"Untergasser","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib21","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","article-title":"The sequence alignment\/map format and SAMtools","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib22","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4161\/fly.19695","article-title":"A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3","volume":"6","author":"Cingolani","year":"2012","journal-title":"Fly (Austin)"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib23","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/nar\/29.1.308","article-title":"dbSNP: the NCBI database of genetic variation","volume":"29","author":"Sherry","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib24","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/bioinformatics\/btp698","article-title":"Fast and accurate long-read alignment with Burrows-Wheeler transform","volume":"26","author":"Li","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib25","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/bioinformatics\/btr629","article-title":"Feature-based classifiers for somatic mutation detection in tumour-normal paired sequencing data","volume":"28","author":"Ding","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib26","doi-asserted-by":"crossref","first-page":"D749","DOI":"10.1093\/nar\/gkt1196","article-title":"Ensembl 2014","volume":"42","author":"Flicek","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib27","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.compbiolchem.2008.07.021","article-title":"A fundamental study of the PCR amplification of GC-rich DNA templates","volume":"32","author":"Mamedov","year":"2008","journal-title":"Comput Biol Chem"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib28","first-page":"155","article-title":"Pitfalls of quantitative real-time reverse-transcription polymerase chain reaction","volume":"15","author":"Bustin","year":"2004","journal-title":"J Biomol Tech"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib29","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1109016","article-title":"SF3B1 and other novel cancer genes in chronic lymphocytic leukemia","volume":"365","author":"Wang","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib30","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1182\/blood-2015-05-647578","article-title":"Presence of multiple recurrent mutations confers poor trial outcome of relapsed\/refractory CLL","volume":"126","author":"Guieze","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib31","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.3109\/10428194.2014.898760","article-title":"NOTCH1, SF3B1, BIRC3 and TP53 mutations in patients with chronic lymphocytic leukemia undergoing first-line treatment: correlation with biological parameters and response to treatment","volume":"55","author":"Chiaretti","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib32","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1182\/blood.V124.21.703.703","article-title":"Clinical significance of genetic aberrations in diffuse large B cell lymphoma","volume":"124","author":"Ennishi","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib33","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1158\/1078-0432.CCR-15-2305","article-title":"Next-generation sequencing in diffuse large B-cell lymphoma highlights molecular divergence and therapeutic opportunities: a LYSA Study","volume":"22","author":"Dubois","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib34","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nature11378","article-title":"Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics","volume":"490","author":"Schmitz","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib35","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1182\/blood-2014-10-604959","article-title":"Mutations in CHD2 cause defective association with active chromatin in chronic lymphocytic leukemia","volume":"126","author":"Rodriguez","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib36","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nature09730","article-title":"Inactivating mutations of acetyltransferase genes in B-cell lymphoma","volume":"471","author":"Pasqualucci","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib37","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1158\/2159-8290.CD-16-0975","article-title":"CREBBP inactivation promotes the development of HDAC3-dependent lymphomas","volume":"7","author":"Jiang","year":"2017","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib38","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/ng.518","article-title":"Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin","volume":"42","author":"Morin","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib39","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1158\/1078-0432.CCR-15-2123","article-title":"Genetic landscapes of relapsed and refractory diffuse large B-cell lymphomas","volume":"22","author":"Morin","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib40","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1182\/blood-2013-01-479865","article-title":"Analysis of FOXO1 mutations in diffuse large B-cell lymphoma","volume":"121","author":"Trinh","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib41","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/nature13765","article-title":"Loss of signalling via Galpha13 in germinal centre B-cell-derived lymphoma","volume":"516","author":"Muppidi","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib42","first-page":"4771","article-title":"ID3 mutations are recurrent events in double-hit B-cell lymphomas","volume":"33","author":"Gebauer","year":"2013","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib43","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature10113","article-title":"Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia","volume":"475","author":"Puente","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib44","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1073\/pnas.1205299110","article-title":"Genetic heterogeneity of diffuse large B-cell lymphoma","volume":"110","author":"Zhang","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib45","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/ni.2688","article-title":"MEF2B mutations lead to deregulated expression of the oncogene BCL6 in diffuse large B cell lymphoma","volume":"14","author":"Ying","year":"2013","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib46","doi-asserted-by":"crossref","first-page":"7953","DOI":"10.1038\/ncomms8953","article-title":"MEF2B mutations in non-Hodgkin lymphoma dysregulate cell migration by decreasing MEF2B target gene activation","volume":"6","author":"Pon","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib47","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1038\/nm.3940","article-title":"Disruption of KMT2D perturbs germinal center B cell development and promotes lymphomagenesis","volume":"21","author":"Zhang","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib48","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nature09671","article-title":"Oncogenically active MYD88 mutations in human lymphoma","volume":"470","author":"Ngo","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib49","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1084\/jem.20110921","article-title":"Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation","volume":"208","author":"Fabbri","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib50","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1182\/blood.V124.21.891.891","article-title":"Notch2 is critical for CLL development in the IRF4 -\/- Vh11 mice","volume":"124","author":"Shukla","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib51","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1084\/jem.20120910","article-title":"Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma","volume":"209","author":"Kiel","year":"2012","journal-title":"J Exp Med"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib52","doi-asserted-by":"crossref","first-page":"63362","DOI":"10.18632\/oncotarget.11457","article-title":"Control of translational activation by PIM kinase in activated B-cell diffuse large B-cell lymphoma confers sensitivity to inhibition by PIM447","volume":"7","author":"Peters","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib53","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.1158\/1078-0432.CCR-15-3103","article-title":"A quantitative analysis of subclonal and clonal gene mutations before and after therapy in chronic lymphocytic leukemia","volume":"22","author":"Amin","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib54","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/ng.2900","article-title":"Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma","volume":"46","author":"Gunawardana","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib55","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10351","article-title":"Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma","volume":"476","author":"Morin","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib56","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1182\/blood-2014-06-582650","article-title":"Activating STAT6 mutations in follicular lymphoma","volume":"125","author":"Yildiz","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib57","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1182\/blood.V128.22.3037.3037","article-title":"Differential expression of TCF3 target genes defines subclasses of diffuse large B-cell lymphoma with striking differences in clinical outcome following R-CHOP therapy","volume":"128","author":"Tyryshkin","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib58","doi-asserted-by":"crossref","first-page":"9166","DOI":"10.1158\/0008-5472.CAN-10-2460","article-title":"Acquired TNFRSF14 mutations in follicular lymphoma are associated with worse prognosis","volume":"70","author":"Cheung","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib59","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1073\/pnas.1121343109","article-title":"Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing","volume":"109","author":"Lohr","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib60","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1182\/blood-2008-05-154013","article-title":"The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survival","volume":"112","author":"O'Shea","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib61","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/ng.892","article-title":"Analysis of the coding genome of diffuse large B-cell lymphoma","volume":"43","author":"Pasqualucci","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib62","doi-asserted-by":"crossref","first-page":"e1002197","DOI":"10.1371\/journal.pmed.1002197","article-title":"Histological transformation and progression in follicular lymphoma: a Clonal Evolution Study","volume":"13","author":"Kridel","year":"2016","journal-title":"PLoS Med"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib63","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1053\/j.seminhematol.2015.01.005","article-title":"The genetic landscape of diffuse large B-cell lymphoma","volume":"52","author":"Pasqualucci","year":"2015","journal-title":"Semin Hematol"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib64","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/MOH.0000000000000255","article-title":"The routes for transformation of follicular lymphoma","volume":"23","author":"Okosun","year":"2016","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib65","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1182\/blood-2016-11-747022","article-title":"Genetic profiling of MYC and BCL2 in diffuse large B-cell lymphoma determines cell-of-origin-specific clinical impact","volume":"129","author":"Ennishi","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib66","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nature15395","article-title":"Mutations driving CLL and their evolution in progression and relapse","volume":"526","author":"Landau","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib67","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1084\/jem.20120904","article-title":"The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development","volume":"209","author":"Rossi","year":"2012","journal-title":"J Exp Med"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib68","doi-asserted-by":"crossref","first-page":"e108747","DOI":"10.1371\/journal.pone.0108747","article-title":"The truncate mutation of Notch2 enhances cell proliferation through activating the NF-\u03baB signal pathway in the diffuse large B-cell lymphomas","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib69","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.jmoldx.2013.07.004","article-title":"A clinically validated diagnostic second-generation sequencing assay for detection of hereditary BRCA1 and BRCA2 mutations","volume":"15","author":"Bosdet","year":"2013","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib70","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/leu.2015.357","article-title":"Recurrent activating mutations of CD28 in peripheral T-cell lymphomas","volume":"30","author":"Rohr","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib71","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/nbt.1975","article-title":"Performance comparison of exome DNA sequencing technologies","volume":"29","author":"Clark","year":"2011","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jmoldx.2017.11.010_bib72","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/1471-2105-14-195","article-title":"Quantifying single nucleotide variant detection sensitivity in exome sequencing","volume":"14","author":"Meynert","year":"2013","journal-title":"BMC Bioinformatics"}],"container-title":["The Journal of Molecular Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157817304257?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525157817304257?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T07:50:39Z","timestamp":1576223439000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525157817304257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":72,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S1525157817304257"],"URL":"https:\/\/doi.org\/10.1016\/j.jmoldx.2017.11.010","relation":{},"ISSN":["1525-1578"],"issn-type":[{"value":"1525-1578","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of Capture and Amplicon-Based Approaches for the Development of a Targeted Next-Generation Sequencing Pipeline to Personalize Lymphoma Management","name":"articletitle","label":"Article Title"},{"value":"The Journal of Molecular Diagnostics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmoldx.2017.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Society for Investigative Pathology and the Association for Molecular Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}